July 29, 2008 - Lung cancer presents a special challenge to clinicians attempting to evaluate the effectiveness of radiation treatment and determine the total dose of radiation received by the tumor and surrounding tissues.

The reason is simple: lung tumors change position as an individual breathes during medical scans. This unavoidable movement of the lungs makes it difficult to accurately assess tumor volume (particularly in the very small malignant nodules that are more treatable if detected early) and track any changes in size that may have resulted from treatment.

Issam M. El Naqa, an assistant professor of radiation oncology at Washington University in St. Louis, and his colleagues have devised a novel solution. Their semi-automated system combines two types of computer algorithms previously only used separately to process data from computerized tomography (CT) scans of the lungs.

So-called deformable regression algorithms are used to create a consistent set of coordinates on which tumor position and size can be mapped over the course of treatment, and segmentation algorithms allow tumors to be precisely located and distinguished from other lung tissue (or "segmented") in CT images. El Naqa and his colleagues, realizing that "both approaches could significantly benefit from the results of the other algorithm if coupled in the same framework," created a new program that does just that.

El Naqa, who has tested the combination algorithm in a preliminary study of four people with non-small cell lung cancer, says that the method provides more accurate and consistent results for tracking tumor changes. He says the technique "would allow us to learn more about tumor response to treatment and potentially be used in treatment adaptation," or, perhaps, in the pre-planning of treatment strategies that would reduce the overall levels of toxic radiation received by people undergoing radiotherapy for lung cancer.

For more information: www.aapm.org

Source: American Association of Physicists in Medicine


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Subscribe Now